AAAAAA

   
Results: 1-8 |
Results: 8

Authors: Ashby, J Lefevre, PA
Citation: J. Ashby et Pa. Lefevre, Replacement of surgical castration by GnRH inhibition for rat prostate androgen receptor preparations, J APPL TOX, 21(5), 2001, pp. 353-354

Authors: Sohoni, P Lefevre, PA Ashby, J Sumpter, JP
Citation: P. Sohoni et al., Possible androgenic/anti-androgenic activity of the insecticide fenitrothion, J APPL TOX, 21(3), 2001, pp. 173-178

Authors: Ashby, J Odum, J Paton, D Lefevre, PA Beresford, N Sumpter, JP
Citation: J. Ashby et al., Re-evaluation of the first synthetic estrogen, 1-keto-1,2,3,4-tetrahydrophenanthrene, and bisphenol A, using both the ovariectomised rat model used in 1933 and additional assays, TOX LETT, 115(3), 2000, pp. 231-238

Authors: Ashby, J Lefevre, PA
Citation: J. Ashby et Pa. Lefevre, Preliminary evaluation of the major protocol variables for the Hershbergercastrated male rat assay for the detection of androgens, antiandrogens, and metabolic modulators, REGUL TOX P, 31(1), 2000, pp. 92-105

Authors: Ashby, J Lefevre, PA
Citation: J. Ashby et Pa. Lefevre, The peripubertal male rat assay as an alternative to the Hershberger castrated male rat assay for the detection of anti-androgens, oestrogens and metabolic modulators, J APPL TOX, 20(1), 2000, pp. 35-47

Authors: Elsby, R Ashby, J Sumpter, JP Brooks, AN Pennie, WD Maggs, JL Lefevre, PA Odum, J Beresford, N Paton, D Park, BK
Citation: R. Elsby et al., Obstacles to the prediction of estrogenicity from chemical structure: Assay-mediated metabolic transformation and the apparent promiscuous nature of the estrogen receptor, BIOCH PHARM, 60(10), 2000, pp. 1519-1530

Authors: Fletcher, K Soames, AR Tinwell, H Lefevre, PA Ashby, J
Citation: K. Fletcher et al., Hepatic gene mutations induced in Big Blue (TM) rats by both the potent rat liver azo-carcinogen 6BT and its reported noncarcinogenic analogue 5BT, ENV MOL MUT, 34(2-3), 1999, pp. 148-153

Authors: Ashby, J Tinwell, H Pennie, W Brooks, AN Lefevre, PA Beresford, N Sumpter, JP
Citation: J. Ashby et al., Partial and weak oestrogenicity of the red wine constituent resveratrol: Consideration of its superagonist activity in MCF-7 cells and its suggested cardiovascular protective effects, J APPL TOX, 19(1), 1999, pp. 39-45
Risultati: 1-8 |